Hello David. I have no current position in this stock, but have traded it. I am interested in what the red flags are that you speak about. I understand their technology and what the study is trying to prove - but seriously what are the red flags? Tia.
1.) We are only in Phase II trial.
2.) We have absolutely no data on how well it's working so far (even the company doesn't know)
3.) The company wasn't given a breakthrough drug status by FDA at the end of the first trial.
4.) They guided 64th event to happen in this quarter, everyone was expecting Q1 of 2014.
5.) They say that it's going to take 4 months to analyze data - very fishy.
6.) There is a lot of optimism and pumping going on. When this happens, crush usually follows.
that's it is in phase 2! and will have to do an additional trial after this one. Look at Celldex, with a much larger market cap, but also immunotherapy: they're in phase 3.
It will take till 2018 when ICT will be on the market and not early 2015.